ArticleNucleic acids research2026
Acquisition of a novel restriction modification system regulates genetic flux and gene expression in the hypervirulent and globally disseminated CC17 lineage of group B Streptococcus.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
DNA methylation is a universal mechanism of epigenetic control that in bacteria can regulate genetic flux and gene expression, contributing to the emergence and success of discrete lineages. The CC17 lineage of the important multi-host pathogen group B Streptococcus has emerged as a hypervirulent clone in human neonates, the molecular basis for which remains elusive. In this study we identify a novel type II restriction modification system that is uniquely associated with the CC17 clade. Using in vitro and in vivo techniques, we show that this system acts as a barrier to genetic exchange, which drives the genetic recalcitrance and low levels of homologous recombination associated with the CC17 clade. Strikingly, the restriction modification system also directly regulates expression of the transcriptional activator NanR and promotes murine vaginal colonization and ascension to the uterus, implicating a role for DNA methylation in promoting persistence at polymicrobial mucosal surfaces. Together, these findings reveal for the first time the importance of restriction modification system activity in defining the lineage structure and virulence potential of group B Streptococcus, uncovering a novel mechanism that underpins the global success of the CC17 clade as a major neonatal pathogen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.